B. AYGEN Et Al. , "ledipasvir plus sofosbuvir treatment in patients with hepatitis C genotype 4d infection:preliminary study," hepatol international 2017 , 2017
AYGEN, B. Et Al. 2017. ledipasvir plus sofosbuvir treatment in patients with hepatitis C genotype 4d infection:preliminary study. hepatol international 2017 .
AYGEN, B., TAHERİ, S., GÖKAHMETOĞLU, S., YILDIZ, O., & BALTACI, S., (2017). ledipasvir plus sofosbuvir treatment in patients with hepatitis C genotype 4d infection:preliminary study . hepatol international 2017
AYGEN, BİLGEHAN Et Al. "ledipasvir plus sofosbuvir treatment in patients with hepatitis C genotype 4d infection:preliminary study," hepatol international 2017, 2017
AYGEN, BİLGEHAN Et Al. "ledipasvir plus sofosbuvir treatment in patients with hepatitis C genotype 4d infection:preliminary study." hepatol international 2017 , 2017
AYGEN, B. Et Al. (2017) . "ledipasvir plus sofosbuvir treatment in patients with hepatitis C genotype 4d infection:preliminary study." hepatol international 2017 .
@conferencepaper{conferencepaper, author={BİLGEHAN AYGEN Et Al. }, title={ledipasvir plus sofosbuvir treatment in patients with hepatitis C genotype 4d infection:preliminary study}, congress name={hepatol international 2017}, city={}, country={}, year={2017}}